The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells
Viruses · 2023
DOI: 10.3390/v15030804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Eduardo Alvarez-Rivera und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Proteomics Facility, Department of Microbiology and Immunology, Universidad Central del Caribe School of Medicine, Bayamόn, PR 00960, USA. Hauptthemen laut MEDLINE: Antiviral Agents, HIV-1, Proteoglycans. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, The Puerto Rico Science, Technology and Research Trust (PRSTRT), INBRE-PR NIH.
Abstract (Originalsprache)
Actin depolymerization factor (ADF) cofilin-1 is a key cytoskeleton component that serves to lessen cortical actin. HIV-1 manipulates cofilin-1 regulation as a pre- and post-entry requisite. Disruption of ADF signaling is associated with denial of entry. The unfolded protein response (UPR) marker Inositol-Requiring Enzyme-1α (IRE1α) and interferon-induced protein (IFN-IP) double-stranded RNA- activated protein kinase (PKR) are reported to overlap with actin components. In our published findings, Coriolus versicolor bioactive extract polysaccharide peptide (PSP) has demonstrated anti-HIV replicative properties in THP1 monocytic cells. However, its involvement towards viral infectivity has not been elucidated before. In the present study, we examined the roles of PKR and IRE1α in cofilin-1 phosphorylation and its HIV-1 restrictive roles in THP1. HIV-1 p24 antigen was measured through infected supernatant to determine PSP’s restrictive potential. Quantitative proteomics was performed to analyze cytoskeletal and UPR regulators. PKR, IRE1α, and cofilin-1 biomarkers were measured through immunoblots. Validation of key proteome markers was done through RT-qPCR. PKR/IRE1α inhibitors were used to validate viral entry and cofilin-1 phosphorylation through Western blots. Our findings show that PSP treatment before infection leads to an overall lower infectivity. Additionally, PKR and IRE1α show to be key regulators in cofilin-1 phosphorylation and viral restriction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Proteomics Facility, Department of Microbiology and Immunology, Universidad Central del Caribe School of Medicine, Bayamόn, PR 00960, USA.
- Department of Microbiology, Houston Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
ORCID-Profile: Eduardo Alvarez-Rivera
Förderung
- NIGMS NIH HHS
- The Puerto Rico Science, Technology and Research Trust (PRSTRT)
- INBRE-PR NIH
- Universidad Central del Caribe pre-doctoral
Zitieren
APA
Alvarez-Rivera, E., Rodríguez-Valentín, M., & Boukli, N. M. (2023). The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells. Viruses. https://doi.org/10.3390/v15030804
Vancouver
Alvarez-Rivera E, Rodríguez-Valentín M, Boukli NM. The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells. Viruses. 2023. doi:10.3390/v15030804
BibTeX
@article{AlvarezRivera2023,
author = {Alvarez-Rivera, Eduardo and Rodríguez-Valentín, Madeline and Boukli, Nawal M},
title = {The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15030804}
}
EUVIMED